FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML

Yan Song(Chinese Academy of Medical Sciences & Peking Union Medical College), Sung Won Choi(University of Michigan), Attaphol Pawarode(University of Michigan), Andrew C. Harris(Primary Children's Hospital), Thomas Braun(Justus-Liebig-Universität Gießen), David A. Hanauer(Associated Press), Mary Riwes(University of Michigan), Komal Chughtai(University of Michigan), John E. Levine(Icahn School of Medicine at Mount Sinai), Erin Gatza(Pediatrics and Genetics), Steven A. Goldstein(University of California, Irvine), Carrie L. Kitko(Vanderbilt University Medical Center), Lin Chang(Geisinger Medical Center), Gregory A. Yanik(University of Michigan), Brian Parkin(AdventHealth Orlando), Dale L. Bixby(University of Michigan), Y Li(University of Michigan), Daniel Couriel, John Magenau(University of Michigan), P Reddy(University of Michigan), J. Connelly(University of Tennessee at Martin)
Bone Marrow Transplantation
July 20, 2015
Cited by 51


Related Papers